AU Stock MarketDetailed Quotes
RGT Argent Biopharma Ltd
- 0.270
- +0.020+8.00%
20min DelayMarket Closed Nov 29 13:56 AET
14.65MMarket Cap-569P/E (Static)
0.270High0.250Low2.10KVolume0.250Open0.250Pre Close565.00Turnover0.57052wk High0.01%Turnover Ratio54.27MShares0.15052wk Low-0.474EPS TTM8.56MFloat Cap0.570Historical HighLossP/E (Static)31.71MShs Float0.150Historical Low-0.474EPS LYR8.00%Amplitude--Dividend TTM-2.84P/B1Lot Size--Div YieldTTM
Argent Biopharma Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | -155.29%-1.14M | -3.74%2.06M | -20.78%2.14M | 295.09%2.7M | 12.45%-1.38M | -1.58M |
| Revenue from customers | -64.68%1.4M | -37.92%3.96M | 194.89%6.38M | 4.37%2.16M | 110.34%2.07M | --985.2K |
| Income from government grants | 397.32%6K | -410.46%-2.02K | --650 | ---- | ---- | ---- |
| Other cash income from operating activities | -33.74%-2.54M | 55.20%-1.9M | -893.59%-4.24M | 115.47%534.53K | -34.72%-3.45M | ---2.56M |
| Cash paid | 4.88%-13.12M | 3.33%-13.79M | 2.84%-14.27M | -73.76%-14.69M | -72.32%-8.45M | -4.91M |
| Payments to suppliers for goods and services | 4.88%-13.12M | 3.33%-13.79M | 2.84%-14.27M | -73.76%-14.69M | -72.32%-8.45M | ---4.91M |
| Direct interest paid | 98.81%-3.06K | -911.29%-257.4K | -244.05%-25.45K | 94.54%-7.4K | -30,436.49%-135.58K | ---444 |
| Direct interest received | ---- | -20.27%240 | -96.23%301 | -43.94%7.98K | -91.00%14.24K | --158.19K |
| Direct tax refund paid | ---- | ---- | ---- | ---- | ---- | ---27.32K |
| Operating cash flow | -18.90%-14.26M | 1.35%-11.99M | -1.41%-12.16M | -20.42%-11.99M | -56.70%-9.96M | ---6.35M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -123.12%-140.12K | 154.55%606.2K | 25.61%-1.11M | -54.02%-1.49M | -2.41%-969.88K | -947.04K |
| Net PPE purchase and sale | 26.20%-140.12K | 92.95%-189.87K | -207.31%-2.69M | 8.39%-876.36K | -153.72%-956.63K | ---377.04K |
| Net business purchase and sale | ---- | ---- | 98.78%-4.55K | -2,716.55%-373.25K | 97.68%-13.25K | ---569.99K |
| Net investment purchase and sale | ---- | ---- | ---- | --302.82K | ---- | ---- |
| Net other investing changes | ---- | -49.82%796.07K | 390.03%1.59M | ---547K | ---- | ---- |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -123.12%-140.12K | 154.55%606.2K | 25.61%-1.11M | -54.02%-1.49M | -2.41%-969.88K | ---947.04K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 52.74%14.87M | -0.05%9.73M | -42.89%9.74M | 62.98%17.05M | 38,627.72%10.46M | 27.01K |
| Net issuance payments of debt | ---- | 11,563.92%7.16M | -98.93%61.42K | --5.75M | ---- | ---- |
| Net common stock issuance | 445.48%15.1M | -72.14%2.77M | -14.00%9.94M | 1.08%11.56M | 42,223.21%11.43M | --27.01K |
| Net other financing activities | -18.77%-238.68K | 23.59%-200.96K | -2.74%-263.01K | 73.64%-255.99K | ---971.29K | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 52.74%14.87M | -0.05%9.73M | -42.89%9.74M | 62.98%17.05M | 38,627.72%10.46M | --27.01K |
| Net cash flow | ||||||
| Beginning cash position | -87.29%239.82K | -65.28%1.89M | 190.02%5.43M | -20.42%1.87M | -76.12%2.35M | --9.86M |
| Current changes in cash | 128.00%463.71K | 53.11%-1.66M | -198.99%-3.53M | 867.49%3.57M | 93.61%-464.85K | ---7.27M |
| Effect of exchange rate changes | -106.95%-658 | 161.86%9.46K | -96.14%-15.3K | 50.85%-7.8K | 93.12%-15.87K | ---230.66K |
| End cash Position | 193.08%702.87K | -87.29%239.82K | -65.28%1.89M | 190.02%5.43M | -20.42%1.87M | --2.35M |
| Free cash from | -18.20%-14.4M | 17.96%-12.18M | 3.04%-14.85M | -40.28%-15.32M | -62.57%-10.92M | ---6.72M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data